# A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)

> **NCT00101439** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 58 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00101439
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-10
- **Primary completion:** 2006-10-24
- **Final completion:** 2006-11-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00101439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00101439, "A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00101439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*